What is Odyssey Health Inc's earnings per share (EPS)?

Odyssey Health Inc (ODYY) reported diluted earnings per share of $-0.02 for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Odyssey Health Inc Financials

ODYY

Source SEC Filings (10-K/10-Q) Data as of Apr 30, 2026 Currency USD FYE July

This page shows Odyssey Health Inc (ODYY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ODYY FY2025 2026-06-12

Odyssey Health’s external funding loop is dominating the picture, with liquidity eroding faster than cash burn improves.

The most important shift is that operating cash burn improved from -$1.2M in FY2024 to -$347K in FY2025, but that did not translate into a safer balance sheet. Cash and equivalents still fell to $26K while current liabilities rose to $7.3M, so the business became less liquid even as annual cash use narrowed.

The current ratio moved from 0.1x in FY2022 to 0.02x in FY2025, a sign that near-term obligations expanded much faster than assets that can cover them. That pattern makes the company look creditor-financed in the short run, not internally financed by ongoing operations.

Financing pressure changed form rather than disappearing: interest expense dropped from $836K in FY2022 to $253K in FY2025. But shares outstanding reached 99.9M and equity was still -$7.2M, which suggests the lighter interest bill reflects a different funding mix, not a repaired capital base.

Financial Health Signals

Financial health score pending refresh

We are recalculating Odyssey Health Inc's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$-0.02

YoY-100.0%

Odyssey Health Inc earned $-0.02 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$26K

YoY-52.5%

5Y CAGR-38.6%

10Y CAGR+16.0%

Odyssey Health Inc held $26K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

100M

YoY+3.3%

5Y CAGR+2.0%

10Y CAGR-1.4%

Odyssey Health Inc had 100M shares outstanding in fiscal year 2025. This represents an increase of 3.3% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

YoY-100.0%

Odyssey Health Inc invested $0 in research and development in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

ODYY Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	$0
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	$0
Gross Profit	N/A	N/A	N/A	N/A	N/A	$0
R&D Expenses	$0-100.0%	$55K-67.5%	$170K	N/A	$1.6M+7967.4%	$20K
SG&A Expenses	N/A	N/A	$2.1M-27.3%	$2.9M	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$253K-51.3%	$518K-15.6%	$614K-26.6%	$836K-22.0%	$1.1M+113.5%	$502K
Income Tax	$0	$0	$0	$0	$0	$0
Net Income	N/A	-$842K	N/A	N/A	N/A	N/A
EPS (Diluted)	$-0.02-100.0%	$-0.01+85.7%	$-0.07+22.2%	$-0.09+50.0%	$-0.18	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	$0	$0	$0	N/A
SG&A Expenses	$298K+63.5%	$182K-40.0%	$303K	N/A	$129K-17.6%	$157K-73.0%	$579K	N/A
Operating Income	-$298K-63.5%	-$182K+40.0%	-$303K	N/A	-$129K+17.6%	-$157K+73.0%	-$579K	N/A
Interest Expense	$528K+27.9%	$412K+332.6%	$95K	N/A	$61K-3.2%	$63K-7.8%	$69K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$766K+121.3%	-$3.6M-645.0%	-$483K	N/A	-$252K-14.4%	-$220K+78.4%	-$1.0M	N/A
EPS (Diluted)	$0.01+133.3%	$-0.03	$0.00	N/A	$0.00	$0.00+100.0%	$-0.01	N/A

ODYY Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$144K-57.9%	$341K-44.3%	$612K-29.5%	$868K-6.9%	$932K+133.8%	$399K
Current Assets	$144K-21.3%	$183K-67.6%	$563K-31.1%	$817K-12.3%	$932K+135.7%	$395K
Cash & Equivalents	$26K-52.5%	$54K-72.8%	$198K+291.9%	$50K-89.3%	$471K+60.9%	$293K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$7.3M+10.3%	$6.6M-3.1%	$6.8M+9.3%	$6.3M+59.2%	$3.9M+314.1%	$949K
Current Liabilities	$7.3M+10.3%	$6.6M-3.1%	$6.8M+9.3%	$6.3M+59.2%	$3.9M+337.1%	$899K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	$50K
Total Equity	-$7.2M-14.0%	-$6.3M-1.0%	-$6.2M-15.5%	-$5.4M-79.7%	-$3.0M-444.7%	-$550K
Retained Earnings	-$63.2M-1.9%	-$62.0M-2.3%	-$60.6M-7.6%	-$56.3M-18.9%	-$47.4M-60.3%	-$29.6M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$374K-48.2%	$721K+402.2%	$144K+188.8%	$50K-69.8%	$165K-38.4%	$267K-21.8%	$341K-41.8%	$586K
Current Assets	$374K-48.2%	$721K+402.2%	$144K+188.8%	$50K-26.2%	$67K-37.8%	$108K-40.6%	$183K+220.6%	$57K
Cash & Equivalents	$298K-51.7%	$616K+2308.8%	$26K+34.1%	$19K+499.0%	$3K-55.7%	$7K-86.7%	$54K+2164.2%	$2K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$10.1M-10.5%	$11.3M+55.1%	$7.3M+4.2%	$7.0M+207.1%	-$6.5M-197.2%	$6.7M+1.7%	$6.6M+11.8%	$5.9M
Current Liabilities	$10.1M-10.5%	$11.3M+55.1%	$7.3M+4.2%	$7.0M+2.0%	$6.9M+2.0%	$6.7M+1.7%	$6.6M+11.8%	$5.9M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$9.7M+8.0%	-$10.6M-48.1%	-$7.2M-2.9%	-$7.0M-203.8%	$6.7M+203.7%	-$6.5M-2.9%	-$6.3M-17.7%	-$5.3M
Retained Earnings	-$66.1M+1.1%	-$66.8M-5.7%	-$63.2M-0.8%	-$62.7M-0.4%	-$62.5M-0.4%	-$62.2M-0.4%	-$62.0M-1.7%	-$61.0M

ODYY Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$347K+71.4%	-$1.2M+17.6%	-$1.5M0.0%	-$1.5M+53.6%	-$3.2M-389.2%	-$649K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$70K-93.0%	$1.0M+10039.4%	-$10K	N/A	$0	$0
Financing Cash Flow	$294K+62.9%	$181K-87.5%	$1.4M0.0%	$1.4M-47.1%	$2.7M+402.2%	$545K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	-$319K-12.1%	-$284K-0.1%	-$284K-489.2%	-$48K-1104.7%	-$4K+91.4%	-$47K+81.2%	-$249K-290.5%	-$64K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	$70K	$0	N/A	N/A	$0
Financing Cash Flow	$0-100.0%	$875K+201.2%	$291K+5205.4%	-$6K	$0	$0-100.0%	$300K	$0
Dividends Paid	N/A	N/A	N/A	N/A	$0	$0	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ODYY Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-247.0%	N/A	N/A	N/A	N/A
Current Ratio	0.020.0	0.03-0.1	0.08-0.0	0.13-0.1	0.24-0.2	0.44
Debt-to-Equity	-1.02+0.0	-1.05+0.0	-1.10+0.1	-1.16+0.1	-1.31-1.2	-0.09
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	-3.8%	N/A	N/A	N/A
Return on Assets	204.9%+704.2pp	-499.3%-162.7pp	-336.6%	N/A	-153.0%-70.5pp	-82.5%+216.3pp	-298.8%	N/A
Current Ratio	0.04-0.0	0.06+0.0	0.02+0.0	0.010.0	0.010.0	0.02-0.0	0.03+0.0	0.01
Debt-to-Equity	-1.04+0.0	-1.07-0.0	-1.02-0.0	-1.01-0.0	-0.98+0.1	-1.04+0.0	-1.05+0.1	-1.11
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$7.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.02), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Qscreen AI Inc PMEDF

$5.4M

Bioelectronics Corp BIEL

$4.9M

Kelyniam Global Inc KLYG

$8.0M

Stimcell Energetics STME

$5.8M

Adm Tronics ADMT

$2.7M

Frequently Asked Questions

What is Odyssey Health Inc's operating cash flow?

Odyssey Health Inc (ODYY) generated -$347K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Odyssey Health Inc's total assets?

Odyssey Health Inc (ODYY) had $144K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Odyssey Health Inc have outstanding?

Odyssey Health Inc (ODYY) had 100M shares outstanding as of fiscal year 2025.

What is Odyssey Health Inc's current ratio?

Odyssey Health Inc (ODYY) had a current ratio of 0.02 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Odyssey Health Inc's debt-to-equity ratio?

Odyssey Health Inc (ODYY) had a debt-to-equity ratio of -1.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Odyssey Health Inc's cash runway?

Based on fiscal year 2025 data, Odyssey Health Inc (ODYY) had $26K in cash against an annual operating cash burn of $347K. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Odyssey Health Inc's debt-to-equity ratio negative or unusual?

Odyssey Health Inc (ODYY) has negative shareholder equity of -$7.2M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.